Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Iroko Pharmaceuticals LLC

www.iroko.com

Latest From Iroko Pharmaceuticals LLC

Celebrex Study Is Feel Good Story For Pfizer, But Are There Any Real Benefits?

Companies with pipeline pain products may see a smoother path through FDA, but Celebrex already has generic competition in the US, limiting the benefits even if it could get the black box removed from labeling and Pfizer also recently settled a lawsuit for $468 million related to the drug's safety.

Safety Clinical Trials

People In the News: Amicus, Catabasis, Astellas Add Reg/Policy Execs

Andrew Mulberg leaves US FDA for Amicus Therapeutics. Ipsen, Iroko, TapImmune make topside changes.

Appointments Europe

Low NSAID Knowledge, Satisfaction In Consumer Pain Medication Survey

While 60% of consumers use an OTC medicine for pain, nearly a third are not satisfied with the results, according to Kelton Global's research on consumer understanding of pain medication. Nearly half of consumers are not familiar with the term NSAIDs or with FDA recommendations on using the products.

BioPharmaceutical Consumer

Low NSAID Knowledge, Satisfaction In Consumer Pain Medication Survey

While 60% of consumers use an OTC medicine for pain, nearly a third are not satisfied with the results, according to Kelton Global's research on consumer understanding of pain medication. Nearly half of consumers are not familiar with the term NSAIDs or with FDA recommendations on using the products.

Consumer BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Iroko Pharmaceuticals LLC
  • Senior Management
  • Osagie Imasogie, Exec. Chmn. & CEO
    Fred C Krieger, SVP, CFO
    Rohit Mehta, SVP, Corp. Dev.
    Olalekan Andrew Bayode, SVP, Sales
  • Contact Info
  • Iroko Pharmaceuticals LLC
    Phone: (267) 546-3003
    1 Kew Pl.
    150 Rouse Blvd.
    Philadelphia, PA 19112
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register